Efficacy and safety of the intensive dose of rosuvastatin 40mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2.

Shah, Chetan P; Shah, Bhaskar P; Dani, Sameer I; Channa, B B; Lakshmanan, S S; Krishnamani, N C; Mehta, Ashwani; Moorthy, P

Shah, Chetan P; Shah, Bhaskar P; Dani, Sameer I; Channa, B B; Lakshmanan, S S; Krishnamani, N C; Mehta, Ashwani; Moorthy, P.

Afiliação

Shah CP; Interventional Cardiologist, Heart Rhythm Clinic, 3rd Floor, Manu Market, M G Road, Ghatkopar (W), Mumbai 400 086, India. Electronic address: drchetan.shahic@gmail.com.
Shah BP; Interventional Cardiologist, Ashirwad Heart Hospital, Tilak Road, Ghatkopar (E), Mumbai 400 077, India.
Dani SI; Interventional Cardiologist, Lifecare Institute of Medical Sciences & Research, Borsalli Apartment Road, Near Cama Hotel, Khanpur, Ahmedabad, Gujarat, India.
Channa BB; Senior Interventional Cardiologist, The Heart Lab, Flat No. 546, Pocket C-8, Sector 8, Rohini, Delhi 110085, India.
Lakshmanan SS; Senior Consultant Internal Medicine and Diabetology, Priya Nursing Home, No. 6 (Old No. 82), Kappal Polu Street, Old Washermenpet, Chennai 600 021, India.
Krishnamani NC; Senior Interventional Cardiologist, KC 46 A, Ashok Vihar, Phase 1, New Delhi 110 052, India.
Mehta A; Senior Consultant Cardiologist, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi 110 060, India.
Moorthy P; Cardio Thoracic Surgeon, S.R.P. Heart Care Centre, Pallavaram, Chennai 600 043, India.

Indian Heart J ; 68(6): 766-771, 2016.

Article em En | MEDLINE | ID: mdl-27931543

Assuntos

Síndrome Coronariana Aguda/tratamento farmacológico; Rosuvastatina Cálcica/administração & dosagem; Síndrome Coronariana Aguda/sangue; Síndrome Coronariana Aguda/mortalidade; Administração Oral; Adulto; Idoso; LDL-Colesterol/sangue; LDL-Colesterol/efeitos dos fármacos; Relação Dose-Resposta a Droga; Feminino; Seguimentos; Humanos; Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem; Índia/epidemiologia; Masculino; Pessoa de Meia-Idade; Fatores de Risco; Taxa de Sobrevida/tendências; Fatores de Tempo; Resultado do Tratamento

Palavras-chave

Acute coronary syndrome; LDL-C; Pleiotropic; Rosuvastatin; Statins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Coronariana Aguda / Rosuvastatina Cálcica Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Indian Heart J Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google